스위스 - 프랑스어 - Swissmedic (Swiss Agency for Therapeutic Products)

pierre fabre pharma sa - binimetinibum - comprimés pelliculés - binimetinibum 15 mg, excipiens pro compresso obducto. - mélanome avec braf-v600 mutation en combinaison avec encorafenib - synthetika

유럽 연합 - 프랑스어 - EMA (European Medicines Agency)

daiichi sankyo europe gmbh - trastuzumab deruxtecan - néoplasmes du sein - agents antinéoplasiques - breast cancerher2-positive breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-positive breast cancer who have received one or more prior anti-her2-based regimens. her2-low breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-low breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy (see section 4. non-small cell lung cancer (nsclc)enhertu as monotherapy is indicated for the treatment of adult patients with advanced nsclc whose tumours have an activating her2 (erbb2) mutation and who require systemic therapy following platinum-based chemotherapy with or without immunotherapy. gastric cancerenhertu as monotherapy is indicated for the treatment of adult patients with advanced her2-positive gastric or gastroesophageal junction (gej) adenocarcinoma who have received a prior trastuzumab-based regimen.

캐나다 - 프랑스어 - Health Canada

sandoz canada incorporated - pazopanib (chlorhydrate de pazopanib) - comprimé - 200mg - pazopanib (chlorhydrate de pazopanib) 200mg - antineoplastic agents

벨기에 - 프랑스어 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - chlorhydrate de pazopanib 216,7 mg - eq. pazopanib 200 mg - comprimé pelliculé - 200 mg - chlorhydrate de pazopanib 216.7 mg - pazopanib

벨기에 - 프랑스어 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - chlorhydrate de pazopanib 433,4 mg - eq. pazopanib 400 mg - comprimé pelliculé - 400 mg - chlorhydrate de pazopanib 433.4 mg - pazopanib

캐나다 - 프랑스어 - Health Canada

pharmascience inc - pazopanib (chlorhydrate de pazopanib) - comprimé - 200mg - pazopanib (chlorhydrate de pazopanib) 200mg

유럽 연합 - 프랑스어 - EMA (European Medicines Agency)

immunocore ireland limited - tebentafusp - uveal neoplasms - agents antinéoplasiques - kimmtrak is indicated as monotherapy for the treatment of human leukocyte antigen (hla)-a*02:01-positive adult patients with unresectable or metastatic uveal melanoma.

벨기에 - 프랑스어 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - chlorhydrate de pazopanib 216,7 mg - eq. pazopanib 200 mg - comprimé pelliculé - pazopanib

벨기에 - 프랑스어 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - chlorhydrate de pazopanib 433,4 mg - eq. pazopanib 400 mg - comprimé pelliculé - pazopanib

캐나다 - 프랑스어 - Health Canada

natco pharma (canada) inc - pomalidomide - capsule - 1mg - pomalidomide 1mg